stars 1 stars 2 stars 3

Icosagen is a unique European CRDMO, being successfully in the business for more than 26 years as an independent family-owned company. As such, we combine pre-clinical CRO and clinical CDMO development expertise at one single site for therapeutic antibodies, multispecifics, ADCs, and other complex recombinant protein drug candidates. As a CRDMO we discover, develop, and manufacture proteins seamlessly from research concepts into pre-clinical and clinical development stages. This includes everything from small-scale transient productions to stable high producing cell lines, to manufacture clinical GMP materials in our modern 200/1000L GMP facility.

Icosagen Group Questions

The Icosagen Group annual revenue was $3 million in 2026.

Mart Ustav is the CEO of Icosagen Group.

98 people are employed at Icosagen Group.

The NAICS codes for Icosagen Group are [5417, 541, 541713, 54171, 54].

The SIC codes for Icosagen Group are [87, 873].

Top Icosagen Group Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users